4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-031080
President and Chief Executive acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2022-05-19 | Grant or award | +12,000 | 76,595 | D |
Loading xslF345X03/doc4.xml…